NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

NWBO has not even completed an application to any regulatory body according to their filings. If they do, they would be obligated to notify investors through an 8k or regular periodic filing. So far crickets.

Regardless of the endpoint, confounding the data, raise questions as to the validity of the trial. That is the point. NWBO has repeatedly stated both PFS and OS data was confounded due to the trial design. That's a flaw that cant be fixed post hoc.

NWBO hasn't announced any intended pricing yet. The only guidance is from other immunotherapies that uses personalized sources for their production. That would be example like CAR-T which are very expensive treatments.